Objective: Aortic cross-clamp and cardiopulmonary bypass times are independent predictors of postoperative morbidity and mortality. Reducing ischemic times with automated titanium fasteners may improve surgical outcomes. This study compared operative times and costs of titanium fasteners versus hand-tied knots for prosthesis securement in open aortic valve replacement. Methods: A randomized control trial was conducted during a 16-month period at a single university medical center. Patients undergoing elective aortic valve replacement were randomized to the titanium fastener (n = 37) or hand-tied groups (n = 36). Knotting, aortic cross-clamp, cardiopulmonary bypass, and total operating room times were recorded. Hospital charges were also calculated for these procedures. Results: Baseline characteristics, concomitant procedures, prosthetic valve size, and sutures were similar between groups. The titanium fastener group had significantly reduced knotting (7.4 vs. 13.0 minutes, P < 0.001), aortic cross-clamp (69 vs. 90 minutes, P < 0.05), cardiopulmonary bypass (86 vs. 114 minutes, P < 0.05), and total operating room times (234 vs. 266 minutes, P < 0.05). Intraoperative complications occurred more frequently in the hand-tied group compared with the titanium fastener group. Postoperative complications were similar between groups. Operating room costs were significantly higher in the titanium fastener group (US $10,428 vs. US $9671, P = 0.01). Hospitalization costs did not differ significantly between the titanium fastener and hand-tied group (US $23,987 vs. US $21,068, P = 0.12). Conclusions: Titanium fastener use was associated with shorter knotting, aortic cross-clamp, cardiopulmonary bypass, and operating room times and fewer intraoperative complications in open aortic valve replacement, without significantly increasing hospitalization cost. A ortic cross-clamp time (AXT) and cardiopulmonary bypass time (CPBT) are independent predictors of morbidity and mortality in cardiac surgery.
A ortic cross-clamp time (AXT) and cardiopulmonary bypass time (CPBT) are independent predictors of morbidity and mortality in cardiac surgery. [1] [2] [3] [4] New technology that can safely hasten the implantation and securement of valve prostheses could potentially improve surgical outcomes. Titanium fasteners (TFs) are increasingly used in cardiac surgery. [5] [6] [7] Lee et al. 8 established that automated TF devices increased the speed of cardiac valve knot placement in an ex vivo porcine heart model compared with hand-tied (HT) knots. This study also demonstrated superior knot strength and consistency in the TF group. 8 In a retrospective study, Grapow et al. 9 showed a decrease in AXT, CPBT, and overall operating room (OR) time with the use of the TF versus HT knots in isolated minimally invasive mitral valve repair. Significant decreases in OR time with the use of TF compared with intrathoracic suture tying in robotic mitral valve surgery have also been reported. 6 To date, no prospective studies have been published that investigate the impact of TF on operative times in aortic valve replacement (AVR). Any time-savings achieved with TF must be considered in the context of its associated additional cost. The objective of this report was to compare the knotting time, AXT, CPBT, and OR time in open AVR for valves secured with HT knots versus TF knots in a prospective randomized study. A secondary objective was to compare OR and hospital costs in the HT and TF groups.
METHODS
A prospective, randomized study comparing two equally distributed groups of patients undergoing open AVR was conducted at a tertiary care university medical center. Consecutive adult patients (age ≥ 18 years) undergoing elective open AVR surgery between February 1, 2013, and May 31, 2014, were approached to participate in this study. Exclusion criteria included age younger than 18 years, pregnancy, emergent surgery, double-valve surgery, redo AVR, and active endocarditis. This study was also limited to patients who spoke either English or Spanish. Subjects were withdrawn from the study if a simple interrupted or running suture technique was used for implantation of the aortic valve prosthesis (e.g., aortic root replacement).
Randomization entailed a 1:1 allocation ratio between the study groups. A single surgeon performed procedures along with cardiothoracic surgery residents and fellows. Residents and fellows participated in all cases and performed HT knots and used the TF device to secure the prosthetic valve. All prosthetic valves were sewn into the supra-annular position using a standard pledgeted mattress suture technique with pledgeted 2-0 coated polyester suture (Ethicon, Somerville, NJ USA).
Sutures were secured using either the COR-KNOT Titanium Fastener device (LSI SOLUTIONS, Victor, NY USA) or HT knots, depending on the patient's assignment. In the HT group, six throws were used to secure each knot. Subjects were followed during their hospital stay and 30 days after discharge. Medical records were screened to obtain postsurgical echocardiogram reports and any occurrence of late complications (>30 days from surgery).
Outcomes
Primary outcomes included knotting time, AXT, CPBT, and total operative times. Secondary outcomes included intensive care unit and hospital length of stay, total OR and hospitalization cost data, and adverse events. The total knotting time was defined as the time needed to secure and cut all the sutures around the aortic valve prosthesis.
We analyzed hospital charge data including OR and hospital costs. The average estimated total OR cost for each subject was calculated by the sum of the OR time cost, OR supply cost, and a fixed anesthesia cost. At our hospital, the anesthesia cost was estimated to be US $628 for each AVR. Adverse events were categorized as intraoperative, early postoperative (within 30 days of surgery), or late postoperative (>30 days from surgery).
Data Management and Statistical Analysis
Study data were collected and managed using REDCap (REDCap Software; Vanderbilt University, Nashville, TN USA) electronic data capture tools. 10 A randomization schedule was created in Microsoft Office Excel (Microsoft Corporation, Redmond, WA USA) using blocks of four and 1:1 allocation ratio by an investigator not participating in the surgical intervention. The schedule was concealed and uploaded to the REDCap secure server before being destroyed. Patients enrolled in the study acquired a new subject ID generated in REDCap. The program assigned the patient to a randomization arm, which the study investigator could then reveal before the start of the operation.
The primary outcome of average difference in knotting time in the two arms was used to determine the sample size using 90% power and a two-sided type I error rate of 5%. The mean ± SD knotting time for HT was assumed to be 15 ± 6 minutes. With a 30% reduction in knotting time, we calculated an estimated average knotting time for TF of 10.5 minutes. A 10% dropout rate was included into the overall sample size calculation of 80 subjects, 40 in each intervention group.
Statistical analysis was performed using Microsoft Excel (Microsoft Corporation, Redmond, WA USA) and SAS Software 9.3 (SAS Institute Inc, Cary, NC USA). To obtain the knotting time per suture (seconds per suture) for each procedure, the total knotting time was divided by the number of sutures around the prosthesis. Normality of data was assumed using the Kolmogorov-Smirnov test. Normally distributed continuous variables were reported as means ± SD and compared using Student t test. Nonparametric data were described by medians and interquartile ranges and compared using Wilcoxon rank-sum or Fischer exact tests. Categorical data were described as counts and percentages and were compared using χ 2 tests. Statistical significance was considered to exist for P < 0.05.
RESULTS

Patient Characteristics
A total of 80 patients were enrolled in the study; 37 were randomized to the TF group and 36 to the HT group. Seven patients were withdrawn from the study-three subjects underwent aortic root replacement using a running suture technique, one patient requested a minimally invasive AVR procedure, and three subjects had valves secured via an interrupted simple suture technique. No patients were lost at 30-days follow-up.
Clinical characteristics were similar between groups with the exception of a significantly higher incidence of chronic obstructive pulmonary disease in the HT group (Table 1) . There were no significant differences in terms of distribution of concomitant surgery, types of AVR prostheses, AVR prosthetic size, or number of sutures between groups ( Table 2 ). Median lengths of intensive care unit and hospital stay were the same (Table 3) .
Operative Outcomes
The TF group had significantly reduced total knotting time (7.4 vs. 13.0 minutes, P < 0.001) and knotting time per suture (22.6 vs. 38.3 seconds, P < 0.001) compared with the HT group (Fig. 1, Table 3 ). Aortic cross-clamp time (69 vs. 90 minutes, AI, aortic insufficiency; AS, aortic stenosis; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; HT, hand-tied; LVEF, left ventricular ejection fraction; NA, not applicable; NYHA, New York Heart Association; TF, titanium fastener; TIA, transient ischemic attack. P < 0.05), CPBT (86 vs. 114 minutes, P < 0.05), and total OR times (233.6 vs. 265.5 minutes, P < 0.05) were significantly reduced in the TF group (Fig. 2, Table 3 ). Intraoperative complications were more frequent in the HT group; however, the number of complications was not significantly different between the groups (Table 4) . Intraoperative complications included loose knots that required placement of additional sutures, breaking a suture during knot tying or suture fastening, redoing the valve replacement, and reinstitution of cardiopulmonary bypass. One valve was reinstalled because of prosthetic valvular insufficiency in the HT group. This was attributed to distortion of the prosthetic valve geometry. Reinstitution of cardiopulmonary bypass was necessary in four patients in the HT group because of significant bleeding (2), loose sutures requiring two additional sutures (1) , and the aforementioned replacement of the prosthetic aortic valve (1).
Operative and Hospital Costs
Average OR supply costs were significantly greater for TF compared with HT (US $7817 vs. US $6885, P < 0.001) (Fig. 3 , Table 3 ). Average OR time costs were similar between the two groups (US $1959 vs. US $2180, P = 0.062). The average estimated total OR costs were significantly higher for the TF group compared with the HT group (US $10,428 vs. US $9671, P = 0.010). The average total cost of hospital admission was higher for the TF group (US $23,987 vs. US $21,068, P = 0.12), but this increase did not reach statistical significance (Fig. 3, Table 3 ).
Clinical Outcomes
Records of postoperative echocardiograms were obtained in 42 (57.5%) of the 73 enrolled subjects. Echocardiograms were performed a median of 81 days (range: 2-617 days) from surgery. All postoperative echocardiograms showed functioning AVR prostheses without thrombus, mass, paravalvular leak (PVL), or dehiscence. The incidence of early and late complications was similar between the two groups (Table 4) . Two early deaths occurred, one in the TF group and one in the HT group. Three late deaths occurred in this study: two in the HT group and one in the TF group. These early and late deaths were not directly related to the valve surgery.
DISCUSSION
There was a decrease of nearly 6 minutes (43% reduction) in knotting time with TF. In addition, the knotting time per suture was reduced by 41% in the TF group. This correlated with a 21-minute decrease in AXT (23% reduction), a 27-minute decrease in CPBT (24% reduction), and a 31-minute decrease in total OR time (12% reduction). The difference in times may be due to a lower number of intraoperative complications with TF use, whereas, in the HT group, more intraoperative complications occurred that required further intervention.
Titanium fasteners reduced the average AXT by 21 minutes, which is consistent with studies showing a 10-to 30-minute savings in AXTwith newer sutureless valves. [11] [12] [13] The result of this study suggests that surgeons can continue using conventional valves that have known efficacy and durability along with TF devices and still achieve significant OR time-savings. [14] [15] [16] Not only are TF faster than HT knots, but also the TF provide reproducible strength of suture securement. 8, 17 Lee et al. 17 showed that the COR-KNOT device generated more consistent pressure between the valve sewing cuff and underlying tissue, resulting in better seating of the valve prosthesis in an in vitro aortic root model. 17 This study further indicated that the prosthetic sewing cuff attachment pressures in the areas contained within the individual sutures (intrasuture) averaged double that of pressures obtained within the suture area of HT knots or knots secured using a knot pusher. 17 The adjacent attachment pressures in the areas outside of the individual suture (extrasuture) were also higher with the COR-KNOT secured prosthesis compared with those secured with HT knots. 17 Greater intrasuture and extrasuture pressure around the valve annulus complex could theoretically decrease the risk for PVL.
There was a trend toward increased hospital cost in the TF group compared with the HT group, although it was not statistically significant. Any increase in cost must be considered in the context of patient outcomes. A reduction of 21 minutes in AXT and 27 minutes in CPBT could have a significant impact on patient outcomes, which might justify a moderate increase in cost. 1, 3, 4 If TF were shown to reduce PVL, this would be additional justification for the cost increase because reduced PVL could lead to reduced patient symptoms and reinterventions. A larger randomized study is necessary to investigate if any difference exists in patient outcomes with the use of TFs.
This report demonstrates significant AXT, CPBT, and OR time-savings in open AVR. These data should be applicable to many practicing surgeons because most valve surgery is performed through a median sternotomy. The results of the study might also be translatable to minimally invasive AVR. Automated knotting devices such as the COR-KNOT device are believed to facilitate minimally invasive valve surgery. 5, 18 Several retrospective reports exhibited a decrease in operative times with the use of COR-KNOT in minimally invasive mitral valve surgery. 6, 9 A prospective trial evaluating OR times with the use of COR-KNOT in minimally invasive AVR may confirm the OR time-savings reported in this study.
Study Limitations
The baseline characteristics of the study population were not different between the TF and HT groups with the exception of chronic obstructive pulmonary disease. This may explain the higher incidence of prolonged ventilator course and pneumonia observed in the HT group. This study population was not racially diverse, which might impact the generalizability of the study.
The study was not powered to show significant differences in length of stay, morbidity and mortality. Titanium fastener use in this study did not result in a significant difference in the incidence of early or late complications. However, this study was not designed or powered to detect significant differences in these outcomes. Reasonable surrogates for clinical outcomes after cardiac surgery are the operative ischemic times, namely, AXT and CPBT, which were significantly shorter with the use of TF. Cost measurements are valuable because they represent the best available estimates of hospital expenditures and are important in decision-making regarding resource allocation, use of services or technology, and justification of reimbursement. 19 Our OR costs are estimates based on reported charges, including an estimated single fixed anesthesia charge, and may not fully incorporate fixed costs and professional fees, which would actually tend to underestimate the value of time-savings.
It was not feasible to blind the surgeon to patient allocation during the operative procedure, and therefore, Hawthorne effect may have occurred. Residents and fellows of varying levels of training and surgical skill participated in these cases, which contributed to the increased variability in HT speeds. There was less variability in knotting times and fewer intraoperative complications with use of TF, which has a smaller learning curve and is more consistent than HT knots. 8, 17 These factors might have contributed to the difference observed in operative times between the two groups.
CONCLUSIONS
Titanium fasteners reduced knotting times in open AVR. Use of TF was associated with significant decreases in AXT and CPBT times, which influence postoperative morbidity and mortality. Titanium fasteners may lead to decreased intraoperative complications and improved patient outcomes without increasing overall hospital costs. 
